Company Overview
PharmaCyte Biotech is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.” This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed.
Recent News
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
Stock Overview
01/26/2023 04:00 PM EST
Investor Relations
PharmaCyte Biotech, Inc.
Investor Relations Department
T: 917-595-2856
Info@PharmaCyte.com